Covid19 Clinical Trial
Official title:
Understanding the Impact of Public Health Measures Planned for School Reopening During COVID-19 Using Simulation Exercises
Verified date | November 2022 |
Source | The Hospital for Sick Children |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This will be a prospective study simulating return to school for two full days prior to the start of the school year in September. Volunteer students and teachers from six grade ranges will be recruited to participate in the study. In each grade range, there will be two classes that will participate, one that will be assigned to wear face masks/coverings at all times (experimental group/class) and the other that will not wear face masks/coverings at all times (control group/class). Students will be randomized to either the masking at all times (experimental across all grades) or no masking (control across JK-Grade 4) / masking only when physical distance can be maintained (control across Grade 5-Grade 12) class in their appropriate grade. Personal behaviours and person-to-person interactions will be recorded using video cameras. In addition, a safe biological indicator will be applied to the hands to simulate potential asymptomatic infection in a subset of students. Other students will have sanitizer applied so that students are blinded to who has the indicator. Cameras will be used to document how the indicator moves throughout the classroom.
Status | Completed |
Enrollment | 174 |
Est. completion date | August 31, 2020 |
Est. primary completion date | August 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 4 Years to 18 Years |
Eligibility | Inclusion Criteria: • To be included in the study, students must have attended a structure learning environment during 2019-2020 school year and provide informed consent (student in Grade 7 or older) or parental consent (SK - Grade 6) and assent (if appropriate). To be included in the study, teachers must be certified teachers and provide informed consent to participate. Exclusion Criteria: - require additional resources or support beyond what can be provided by the single class teacher - have been exposed to an individual that has tested positive for COVID-19 in the 14 days prior to the simulation - test positive for COVID-19 in the 14 days prior to the simulation - have signs or symptoms of COVID-19, as identified on the screening form (See Screening Form) before the simulations - travel outside Canada in the last 14 days - known hypersensitivity or allergy to the biological indicator (Fluorescein dye/GloGerm) |
Country | Name | City | State |
---|---|---|---|
Canada | The Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total number of hand-to-face contacts per participant per hour | The number of touches to the face made per hour in the simulated school environment | Day 2 | |
Secondary | Total number of hand-to-mucus membrane contacts per participant per hour | The number of touches to the eyes, nose, mouth made per hour in the simulated school environment | Day 2 | |
Secondary | Total number of hand-to-non-mucus membrane contacts per participant per hour | The number of touches to the skin (not eyes, nose, mouth) made per hour in the simulated school environment | Day 2 | |
Secondary | Total number of instances where participants are within 1 and 2 meters of each other | The number of instances where 1 and 2 meter distance between participants is breached in the classroom | Day 2 | |
Secondary | Total number of glo germ transfers to another person | The number of children within a classroom with Glo Germ on the hands/face | Day 2 | |
Secondary | Total number of glo germ transfers to teacher | The presence of Glo Germ on the hands/face of teacher within the same classroom | Day 2 | |
Secondary | Total number of glo germ transfers to a surface | The number of surfaces in the classroom with Glo Germ | Day 2 | |
Secondary | Total number of instances of hand holding per participant per hour | The count of hand holding instances with another person per hour in the simulated school environment | Day 2 | |
Secondary | Total number of touches to another person per participant per hour | The count of touches to another person per hour in the simulated school environment | Day 2 | |
Secondary | Total number of hand hygiene actions per participant per hour | The count of hand hygiene actions (i.e., hand washing, hand sanitizer) per participant per hour | Day 2 | |
Secondary | Total number of mask removals per participant per hour | The number of times a participant in a masking group removes their mask per hour in the simulated school environment | Day 2 | |
Secondary | Teacher concerns measured using study-specific post-simulation questionnaire | A study specific questionnaire that examines teacher anxiety and mental health | Day 2 | |
Secondary | Teacher concerns measured using semi-structured group interviews | A study specific semi-structured interview examining the factors throughout the day (hand hygiene, mask use, physical distancing) that impacted the teaching experience | Day 2 | |
Secondary | Student concerns measured using study-specific post-simulation questionnaire | A study specific questionnaire that examines student anxiety and mental health | Day 2 | |
Secondary | Student concerns measured using semi-structured group interviews | A study specific semi-structured interview examining the factors throughout the day (hand hygiene, mask use, physical distancing) that impacted the learning experience | Day 2 | |
Secondary | Identify activity types that influence touching behaviour | The count of each type of activity participants are engaged in while touching others or surfaces in the simulated school environment | Day 2 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |